Cannabinoid Neuroprotection

Cannabinoid Neuroprotection enters the Adult Cognitive Disease corpus through the work of Pamela Maher (submission 52), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

Pamela Maher's submission is summarised in this corpus as:

The Oxytosis/Ferroptosis hypothesis posits that AD is fundamentally driven by catastrophic failure of redox homeostasis, initiated by glutathione depletion via System Xc- inhibition and subsequent uncontrolled lipid peroxidation. The toxic aldehyde 4-HNE generated during lipid peroxidation directly poisons the lysosomal V-ATPase, providing the biochemical bridge between oxidative stress and autophagic collapse.

Where it sits

The submission scores against the framework's convergence nodes as: endosomal nexus 7 · compensatory paradigm 2 · cytoskeletal collapse 1 · neuroimmune interface 1 · ApoE4 hub 1.

Its declared subject matter: oxytosis, ferroptosis, lipid-peroxidation, glutathione, oxidative-stress, geroneuroprotection, drug-discovery, mitochondrial-dysfunction, V-ATPase, aging, oxytosis-ferroptosis, CBN-neuroprotection.

Named by the same submission

8 other concepts enter the corpus through the same paper, so they cover adjacent ground: Anti Ferroptotic Botanicals · Autophagy · Calcium Homeostasis · Ferroptosis · Lipid Peroxidation · Mitochondrial Dysfunction · Oxidative Stress · TOMM40 Import Gate.

Assembled from the corpus rather than written: the summary is quoted from the submission that named it; the node scores are read from its dossier. It has not yet been expanded into an article.